ArticleCureus2026
The PET-CT Deception: A Postoperative Retroperitoneal Mass Resembling Recurrent Burkitt Lymphoma Following Laparoscopic Colectomy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burkitt lymphoma (BL) is a highly aggressive B-cell non-Hodgkin lymphoma with excellent chemosensitivity when appropriately treated. However, the interpretation of post-operative imaging findings, particularly fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT), remains challenging in distinguishing residual disease from benign post-therapeutic changes. We present the case of a 13-year-old adolescent with ileocecal BL who underwent successful chemotherapy followed by laparoscopic right hemicolectomy with intracorporeal anastomosis. Post-operative PET/CT imaging demonstrated a nodular lesion in the tumor resection bed with increased FDG uptake, raising concern for residual disease. However, adoption of active surveillance demonstrated progressive resolution of the lesion. This case highlights the importance of cautious interpretation of postoperative PET/CT findings, as hypermetabolic lesions may represent benign post-therapeutic changes rather than residual disease. In selected asymptomatic patients with favorable clinical evolution, close surveillance may be considered to avoid unnecessary invasive procedures or overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.